Court Wants To Reassess Damages In NuVasive/Medtronic Patent Fight

In a long-standing patent fight between NuVasive and Medtronic, an appeals court has ruled NuVasive was being penalized twice for lost profits based on damages awarded by a jury. The judges unanimously agreed to send the case back to a district court to reevaluate how much Medtronic should be paid.

More from Archive

More from Medtech Insight